1. Home
  2. INSP vs CNS Comparison

INSP vs CNS Comparison

Compare INSP & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSP
  • CNS
  • Stock Information
  • Founded
  • INSP 2007
  • CNS 1986
  • Country
  • INSP United States
  • CNS United States
  • Employees
  • INSP N/A
  • CNS N/A
  • Industry
  • INSP Medical/Dental Instruments
  • CNS Investment Managers
  • Sector
  • INSP Health Care
  • CNS Finance
  • Exchange
  • INSP Nasdaq
  • CNS Nasdaq
  • Market Cap
  • INSP 3.8B
  • CNS 4.0B
  • IPO Year
  • INSP 2018
  • CNS 2004
  • Fundamental
  • Price
  • INSP $96.04
  • CNS $76.27
  • Analyst Decision
  • INSP Buy
  • CNS Hold
  • Analyst Count
  • INSP 14
  • CNS 3
  • Target Price
  • INSP $167.08
  • CNS $82.00
  • AVG Volume (30 Days)
  • INSP 1.7M
  • CNS 207.2K
  • Earning Date
  • INSP 08-04-2025
  • CNS 10-15-2025
  • Dividend Yield
  • INSP N/A
  • CNS 3.26%
  • EPS Growth
  • INSP 756.73
  • CNS 23.33
  • EPS
  • INSP 1.74
  • CNS 3.15
  • Revenue
  • INSP $861,312,000.00
  • CNS $543,579,000.00
  • Revenue This Year
  • INSP $20.61
  • CNS $7.32
  • Revenue Next Year
  • INSP $17.32
  • CNS $8.15
  • P/E Ratio
  • INSP $52.59
  • CNS $24.19
  • Revenue Growth
  • INSP 22.05
  • CNS 11.54
  • 52 Week Low
  • INSP $73.92
  • CNS $68.99
  • 52 Week High
  • INSP $225.00
  • CNS $110.67
  • Technical
  • Relative Strength Index (RSI)
  • INSP 43.25
  • CNS 54.20
  • Support Level
  • INSP $82.68
  • CNS $71.31
  • Resistance Level
  • INSP $88.72
  • CNS $75.51
  • Average True Range (ATR)
  • INSP 5.39
  • CNS 1.97
  • MACD
  • INSP 1.53
  • CNS 0.05
  • Stochastic Oscillator
  • INSP 99.86
  • CNS 73.41

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for close to two thirds of its $79.3 billion in managed assets at the end of January 2024. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 42% (27%) of its managed assets (base management fees) from institutional clients, 45% (52%) from open-end funds, and 13% (21%) from closed-end funds.

Share on Social Networks: